Aemetis (NASDAQ:AMTX) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Aemetis (NASDAQ:AMTX) from a sell rating to a hold rating in a research note issued to investors on Saturday.

Other research analysts also recently issued research reports about the stock. Ascendiant Capital Markets upped their price objective on shares of Aemetis from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a report on Friday, July 17th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Aemetis presently has an average rating of “Hold” and a consensus price target of $11.88.

Aemetis Price Performance

Shares of NASDAQ AMTX opened at $1.89 on Friday. The company has a 50-day simple moving average of $1.70 and a 200-day simple moving average of $2.08. The company has a market cap of $136.40 million, a PE ratio of -2.08 and a beta of 1.48. Aemetis has a 12 month low of $1.30 and a 12 month high of $3.80.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.16. The firm had revenue of $62.70 million for the quarter, compared to analysts’ expectations of $67.69 million. On average, analysts anticipate that Aemetis will post -0.98 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Royal Bank of Canada increased its stake in Aemetis by 10,632.5% during the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after buying an additional 8,825 shares during the period. Creative Planning acquired a new stake in shares of Aemetis during the second quarter valued at about $30,000. Virtu Financial LLC acquired a new stake in shares of Aemetis during the fourth quarter valued at about $31,000. Sanctuary Advisors LLC purchased a new stake in shares of Aemetis during the first quarter worth about $33,000. Finally, HRT Financial LP purchased a new stake in shares of Aemetis during the fourth quarter worth about $36,000. 27.02% of the stock is currently owned by hedge funds and other institutional investors.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.